Science37, the mobile technology and clinical trials organization, has raised $31M in Series B funding led by Redmile Group with participation from Sanofi-Genzyme BioVentures, dRx Capital, Lux Capital and Redmile Group. Oddly enough, they have now raised a total of $37M over their 2 rounds of funding.
Page 4 of 11
